Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Spastic paraplegia-Paget disease of bone syndrome is an extremely rare, complex form of hereditary spastic paraplegia characterized by a slowly progressive spastic paraplegia (with increased muscle tone, decreased strength in the anterior tibial muscles and hyperreflexia in the lower extremities with Babinski sign) presenting in adulthood, associated with Paget disease of the bone. Cognitive decline, dementia and myopathic changes at muscle biopsy have not been reported.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for spastic paraplegia-Paget disease of bone syndrome.
17 publications have been identified in PubMed for spastic paraplegia-Paget disease of bone syndrome. Research spans Case Report / Case Series (50%), Review / Meta-Analysis (44%), and Epidemiology / Natural History (6%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 8 | 50% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 5:42 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries
7 |
44% |
Disease patterns and progression | 1 | 6% |
Acevedo-Gonzalez JC (2026). [PMID: 41406996](https://pubmed.ncbi.nlm.nih.gov/41406996/). *World neurosurgery*. [Review / Meta-Analysis]
Zeoli T (2025). [PMID: 40493070](https://pubmed.ncbi.nlm.nih.gov/40493070/). *Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery*. [Case Report / Case Series]
Peck A (2025). [PMID: 40037468](https://pubmed.ncbi.nlm.nih.gov/40037468/). *Neurobiology of disease*. [Review / Meta-Analysis]
Bregant E (2025). [PMID: 40208338](https://pubmed.ncbi.nlm.nih.gov/40208338/). *Human genetics*. [Review / Meta-Analysis]
Chen L (2025). [PMID: 39709005](https://pubmed.ncbi.nlm.nih.gov/39709005/). *European journal of medical genetics*. [Case Report / Case Series]
Yamazaki S (2025). [PMID: 40116369](https://pubmed.ncbi.nlm.nih.gov/40116369/). *Immunological medicine*. [Case Report / Case Series]
Osadchyi V (2025). [PMID: 40416147](https://pubmed.ncbi.nlm.nih.gov/40416147/). *Cureus*. [Case Report / Case Series]
Dantam CR (2025). [PMID: 40760574](https://pubmed.ncbi.nlm.nih.gov/40760574/). *Medicine*. [Case Report / Case Series]
Jasińska N (2025). [PMID: 40446099](https://pubmed.ncbi.nlm.nih.gov/40446099/). *Przeglad epidemiologiczny*. [Case Report / Case Series]
Erdogan EN (2025). [PMID: 40317680](https://pubmed.ncbi.nlm.nih.gov/40317680/). *American journal of medical genetics. Part A*. [Review / Meta-Analysis]